Multicenter clinical trial of cefetamet pivoxil vs cefixime in treatment of acute bacterial infections / 中国新药与临床杂志
Chinese Journal of New Drugs and Clinical Remedies
;
(12): 87-90, 2001.
Article
in Chinese
| WPRIM
| ID: wpr-411490
ABSTRACT
AIM:
To evaluate the safety and efficacy of cefetamet pivoxil vs cefixime in the treatment of acute bacterial infections.METHODS:
A multicenter randomized controlled clinical trial was conducted. Ninety-eight patients (M 43, F 55; age 40 a± s 13 a) with acute bacterial infections of cefetamet group were given cefetamet pivoxil 250-500 mg, po, bid, for 7-14 d, and ninty-five patients (M 44, F 51; age 42 a±14 a) of cefixime group were given cefixime 200 mg, po, bid, for 7-14 d.RESULTS:
The overall clinical efficacy rates were 95 % and 94 %, the bacterial clearance rates were 96 % and 94 %, the bacterial sensitive rates were 98 % and 96 %, the adverse reaction rates were 7 % and 6 %, respectively. There was no statistical significance between two groups (P>0.05).CONCLUSION:
Cefetamet pivoxil and cefixime are effective and safe in the treatment of acute bacterial infections.
Full text:
Available
Index:
WPRIM (Western Pacific)
Type of study:
Controlled clinical trial
Language:
Chinese
Journal:
Chinese Journal of New Drugs and Clinical Remedies
Year:
2001
Type:
Article
Similar
MEDLINE
...
LILACS
LIS